Trials / Recruiting
RecruitingNCT07098572
Comparison of Four-Channel Functional Electrical Stimulation vs. One-Channel Electrical Stimulation on Moderate Arm/Hand Paresis in Subacute Stroke Patients
Efficacy of EMG-triggered Four-Channel Functional Electrical Stimulation vs. Cyclic One-Channel Electrical Stimulation on Moderate Arm/Hand Paresis in Subacute Stroke Patients. A Randomized Controlled Single Blinded Multicenter Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- MED-EL Elektromedizinische Geräte GesmbH · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare two treatments that may help participants recover after having suffered from stroke. Persons who experience weakness or paralysis of their arms/hands will be randomly placed in one of two groups. Each receives treatment five times a week for three weeks. One group will be treated with electrostimulation following a cyclic pattern (control treatment), the other group will be treated with electrostimulation triggered by nerve signals (i.e. stimulation starts when they deliberately try to move their arm (investigational treatment). Before and after the three weeks and additionally 12 weeks later, the ability to move the arm and hand will be documented with standardized tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cyclic single channel neuromuscular stimulation | Cyclic single channel neuromuscular stimulation is used to trigger repetitive muscular contractions |
| DEVICE | Electromyogram-triggered 4 channel neuromuscular stimulation | EMG-MES provides biofeedback by using electromyographic signals to trigger muscular contractions |
Timeline
- Start date
- 2025-07-14
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
- First posted
- 2025-08-01
- Last updated
- 2025-08-26
Locations
3 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT07098572. Inclusion in this directory is not an endorsement.